U
UroGen Pharma Ltd. (URGN)
NGM – Real Time Price. Currency in USD
29.80
-1.53 (-4.88%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
29.80
-1.53 (-4.88%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.69 | 6.05 | 10 | |
| Quick ratio | 4.28 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.78 | 1.04 | 2.0 | |
| Interest coverage | -2.33 | -16.91 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 64M | 83M | 90M | 110M | 140M |
| Gross Profit | 57M | 73M | 82M | 97M | 126M |
| Operating Income | -79M | -66M | -97M | -125M | -108M |
| Net Income | -110M | -102M | -127M | -153M | -133M |
| EBITDA | -77M | -64M | -96M | -122M | -106M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 151.94 | 71.55 | 10 |
| Next quarter | 160.66 | 82.97 | 10 |
| Current year | 138.94 | 70.26 | 10 |
| Next year | 66.01 | 246.38 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 34.68 | 10.58 | 12.96 | -6.67 | 6.5 |
| Y/Y | 151.6 | 46.23 | 48.91 | -7.84 | 7.8 |
| 3y average | 19.75 | -12.72 | 11.58 | -27.19 | 4.5 |
| 5y average | 80.08 | -4.69 | 10.82 | -12.81 | 4.8 |
| Weighted average score | 5.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $197.1M significantly exceeds cash reserves ($111.3M), raising financial stability concerns
Total current assets $237.5M exceed Total current liabilities $50.6M, highlighting excellent liquidity
Debt-to-equity ratio (-1.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-2.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$45.4M limits the company's ability to reinvest or pay down debt